Dust Mite Allergy
Dust Mite Allergy
Explore linked clinical trials. Standard reference: MESH:M0007521675 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Identification of B Regulatory Cells by Flow Cytometry | Dust Mite Allergy, Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, perennial allergic rhinitis, respiratory system disorder, rhinitis, seasonal allergic rhinitis, venom allergy | Recruiting | Not stated | 2026-09-17 | NCT06876506 | |
| Dupilumab Effects Against Aeroallergen Challenge | Dust Mite Allergy, Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, asthma, bronchial disorder, immune system disorder, lung disorder, nasal disorder, obstructive lung disease, otorhinolaryngologic disease, perennial allergic rhinitis, respiratory system disorder, rhinitis | Active, not recruiting | Phase 2 | 2026-08-11 | NCT05720325 | |
| Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df | Dust Mite Allergy, Hypersensitivity, Immediate, Infections, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, perennial allergic rhinitis, respiratory system disorder, respiratory tract infectious disorder, rhinitis | Recruiting | Phase 3 | 2026-01-16 | NCT07348302 | |
| Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated With Tezepelumab | Dust Mite Allergy, Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, asthma, bronchial disorder, immune system disorder, lung disorder, nasal disorder, obstructive lung disease, otorhinolaryngologic disease, perennial allergic rhinitis, respiratory system disorder, rhinitis | Not yet recruiting | Phase 3 | 2025-06-10 | NCT07013123 | |
| Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract | Dust Mite Allergy, Hypersensitivity, Immediate, Infections, Respiratory Hypersensitivity, Rhinitis, Allergic, allergic asthma, immune system disorder, nasal disorder, otorhinolaryngologic disease, perennial allergic rhinitis, respiratory system disorder, respiratory tract infectious disorder, rhinitis | Not yet recruiting | Phase 2 / Phase 3 | 2023-10-23 | NCT05641272 |